Article: Texas Heart Institute at St. Luke's Episcopal Hospital Announces Landmark Patient Milestone; Everardo Flores Celebrates 365 Days of Support on the HeartMate(R) II Left Ventricular Assist Device (LVAD) This Week.

HOUSTON, Nov. 9 /PRNewswire/ -- Texas Heart Institute announced this week that Everardo Flores will be the first patient in the world to be supported by the HeartMate(R) II left ventricular assist device (LVAD) for a period of 365 days. Everardo, who celebrates the landmark anniversary on Thursday, received the heart pump as part of a U.S. feasibility pilot study by Thoratec Corporation , manufacturer of the device.

Then 18-year old Everardo was admitted to Texas Heart in October 2003 with severe cardiomyopathy and in need of a transplant. Too weak to withstand the surgery, he was implanted with the HeartMate II to keep him alive while regaining his strength ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!